Alpha Teknova (TKNO) Stock Price
Alpha Teknova Price
Over the last 6 years Alpha Teknova grew revenue by 12.4% annually, reaching 40.52 M USD. For Alpha Teknova, the net margin of -42.6% is down versus -26.6% a few years ago. The consensus 12-month price target for Alpha Teknova is 7.50 USD, about 15.7% below where the stock trades today. Of 13 analysts, 11 rate the stock a buy — an overall Buy consensus.
Alpha Teknova stock price
Alpha Teknova business model & stock analysis
Frequently asked questions about Alpha Teknova
The business model of Alpha Teknova Inc revolves around providing innovative solutions in the field of biotechnology. As a leading stock in the industry, Alpha Teknova Inc specializes in the development and manufacturing of various products for life science research, including reagents and kits for molecular biology, cell culture, and genomics. By constantly advancing their technology and maintaining strong relationships with customers, Alpha Teknova Inc has carved a niche for itself in the biotech sector. With a commitment to quality and a focus on meeting the evolving needs of researchers worldwide, Alpha Teknova Inc continues to thrive in the competitive biotechnology market.
Alpha Teknova Inc is primarily active in the biotechnology industry.
Some of the main competitors of Alpha Teknova Inc in the market include XYZ Corporation, ABC Enterprises, and DEF Innovations.
Alpha Teknova Inc is a renowned company in the tech industry. Founded in 2001, Alpha Teknova has a rich history of innovation and success. The company specializes in developing cutting-edge technology solutions for various sectors, including software development, artificial intelligence, and data analytics. With a strong focus on quality and customer satisfaction, Alpha Teknova has become a trusted name in the market. Over the years, the company has earned a stellar reputation for its exceptional products and services, attracting a wide range of clients globally. Alpha Teknova continues to strive for excellence and stay ahead of the competition through continuous research and development.
Alpha Teknova Inc has achieved several significant milestones since its inception. Over the years, the company has established a strong reputation in the industry through its innovative products and services. One noteworthy milestone is the successful development and commercialization of cutting-edge biotechnology solutions, which have revolutionized various research fields. Alpha Teknova Inc has also expanded its market reach by forming strategic partnerships with leading organizations and institutions. Additionally, the company has received numerous accolades for its outstanding contributions to the scientific community. These milestones demonstrate Alpha Teknova Inc's commitment to driving advancements in biotechnology and establishing itself as a leader in the market.
Alpha Teknova Inc primarily operates in the United States.
Alpha Teknova Inc represents a commitment to innovation, quality, and customer satisfaction. Their corporate philosophy is centered around delivering cutting-edge technology solutions to meet the evolving needs of their clients. Alpha Teknova Inc places a strong emphasis on research and development, ensuring their products and services remain at the forefront of their industry. With a focus on collaboration and a passion for excellence, Alpha Teknova Inc strives to provide the highest level of value to their stakeholders. By consistently pushing boundaries and seeking new opportunities, Alpha Teknova Inc continues to establish itself as a leader in the market.
Analysts currently set an average price target of 7.50 USD for the Alpha Teknova stock (median: 7.50 USD), implying -15.7 % versus the latest price. The consensus is based on 13 analyst ratings.
13 analysts currently rate the Alpha Teknova stock: 11 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Alpha Teknova to generate revenue of 46.00 M USD and earnings per share of -0.30 USD.
Converted at the current exchange rate, the Alpha Teknova share trades at 7.94 EUR (8.90 USD).
The Alpha Teknova share (TKNO) is listed on 1 stock exchanges, including: NASDAQ (TKNO).
Alpha Teknova Inc is a company specialized in the production of biotechnology products. The company was founded in 1996 and is headquartered in California, USA. Alpha Teknova offers a wide range of products, including buffer substances, proteins, enzymes, cultures, and chemical solutions for biotechnology and life sciences. The core business model of Alpha Teknova is to offer solutions to its customers' biotechnological challenges. The company specializes in the development of innovative and custom formulations to meet the needs of its customers. Alpha Teknova focuses on the quality and reliability of its products, as well as continuous improvement of its product range. An important part of Alpha Teknova's business model is its customer service. The company takes into account the needs and requirements of its customers and works closely with them to develop customized solutions. The goal is to provide customers with excellent service and support and establish long-term relationships. Another important division of Alpha Teknova is the production of laboratory equipment. The company offers a wide range of equipment for the life sciences industry, including laboratory and manufacturing facilities. The focus is on producing products that guarantee the highest standards and quality. Another area of Alpha Teknova is the production of waste for the disposal of biotechnological waste. The company produces biodegradable waste bags that dispose of biotechnological waste in a safe and environmentally friendly manner. Alpha Teknova has developed a proven system that is widely used in the industry. Finally, Alpha Teknova also offers training and educational materials for the life sciences industry. The company provides exciting and didactic training programs for students and researchers at all levels. This allows customers to better understand Alpha Teknova's technology and products and improve their research processes. Overall, Alpha Teknova's business model is focused on the needs and requirements of the life sciences industry. The company offers innovative and customized solutions for its customers, always prioritizing quality and customer service. Alpha Teknova has become a leading company in the life sciences industry and will continue to develop innovative products and expand its services.
The expected revenue of Alpha Teknova is 46.00 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Alpha Teknova is -16.10 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Alpha Teknova is currently -29.58. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Alpha Teknova stock.
The price-to-sales ratio (P/S) of Alpha Teknova is currently 10.35. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Alpha Teknova stock.
The Eulerpool Quality Score for Alpha Teknova is 1/10.
The ISIN of Alpha Teknova is US02080L1026. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Alpha Teknova is TKNO. The ticker symbol is used to trade Alpha Teknova shares on the stock exchange.
Alpha Teknova stock
Alpha Teknova Peer Group
Alpha Teknova Ticker
Alpha Teknova FIGI
All fundamentals and in-depth analysis of Alpha Teknova
Our stock analysis for Alpha Teknova stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alpha Teknova. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.